Phase 1bData readout

Auxora/Zegocractin (Zegocractin) (CRAC Channel Inhibitor)

Pulmonary Arterial Hypertension

CALCCalciMedica

Expected catalystAugust 15, 2027Company guidance: Aug 15, 2027

Catalyst overview

Event details

Drug or asset: Auxora/Zegocractin (Zegocractin) (CRAC Channel Inhibitor)
Development stage: Phase 1b
Event type: Data readout
Indication: Pulmonary Arterial Hypertension

Research summary

What is being tracked?

This catalyst tracks a Phase 1b data readout for Auxora/Zegocractin (Zegocractin) (CRAC Channel Inhibitor) in Pulmonary Arterial Hypertension. The expected timing is based on the latest available company guidance and may change.

Development notes

08/11/26:- Financing supports PAH Ph1b; proof-of-concept data still expected Mid-2027.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source